Skip to main content
Midas Edge

PRECISION BIOSCIENCES INC

For the period ended Sep 30, 2025. Filed Nov 3, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 3, 2025

DTIL$9.68-8.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Statements of Changes in Stockholders’ Equity

(In thousands, except share amounts)

Common Stock · AdditionalPaid-InCapital · AccumulatedDeficit · TreasuryStock · TotalStockholders’Equity
Shares · Amount
Balance- December 31, 20234,191,053$1$509,443$(489,631)$(952)$18,861
Issuance of common stock under employee stock purchase plan9,037—112——$112
Share-based compensation expense——2,906——$2,906
Issuance of common stock to collaboration partners and licensees97,360—905——$905
Issuance of common stock and warrants through underwritten offering, net of issuance cost2,500,000—4,610——$4,610
Issuance of common stock through ATM facility, net of issuance cost98,943—1,224——$1,224
Settlement of restricted stock units46,861—————
Net income———8,588—$8,588
Balance- March 31, 20246,943,254$1$519,200$(481,043)$(952)$37,206
Share-based compensation expense——2,928——2,928
Issuance of common stock, net of issuance cost25,000—300——300
Issuance of common stock through ATM facility, net of issuance cost144,735—1,531——1,531
Settlement of restricted stock units37,396—————
Net Income———32,749—32,749
Balance- June 30, 20247,150,385$1$523,959$(448,294)$(952)$74,714
Share-based compensation expense——3,199——3,199
Issuance of common stock under employee stock purchase plan14,794—137——137
Issuance of common stock through ATM facility, net of issuance cost342,357—3,241——3,241
Net loss———(16,425)—(16,425)
Balance- September 30, 20247,507,536$1$530,536$(464,719)$(952)$64,866
Balance- December 31, 20248,229,730$1$539,808$(482,464)$(952)$56,393
Issuance of common stock under employee stock purchase plan30,999—140——140
Share-based compensation expense——2,822——2,822
Issuance of common stock to licensees220,712—1,031——1,031
Issuance of common stock through ATM facility, net of issuance cost1,818,886—9,516——9,516
Settlement of restricted stock units275,540—————
Net loss———(20,565)—(20,565)
Balance- March 31, 202510,575,867$1$553,317$(503,029)$(952)$49,337
Shared-based compensation expense——2,937——2,937
Issuance of common stock through ATM facility, net of issuance cost1,036,488—5,300——5,300
Settlement of restricted stock units51,641—————
Net loss———(23,520)—(23,520)
Balance- June 30, 202511,663,996$1$561,554$(526,549)$(952)$34,054
Shared-based compensation expense——2,386——2,386
Issuance of common stock under employee stock purchase plan18,745—78——78
Issuance of common stock through ATM facility, net of issuance cost382,571—1,888——1,888
Settlement of restricted stock units44,368—————
Net loss———(21,772)—(21,772)
Balance- September 30, 202512,109,680$1$565,906$(548,321)$(952)$16,634
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.